Margaret E. McCann
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Adipose Tissue and Metabolism, Diabetes Treatment and Management, Drug Transport and Resistance Mechanisms, Veterinary Equine Medical Research
Most-Cited Works
- → (2R)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin- 7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes(2004)814 cited
- → In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in dogs with experimentally induced synovitis(2004)114 cited
- → Extracellular loop C of NPC1L1 is important for binding to ezetimibe(2008)114 cited
- → Selective PPARγ modulators with improved pharmacological profiles(2005)62 cited
- → Benzimidazolones: A New Class of Selective Peroxisome Proliferator-Activated Receptor γ (PPARγ) Modulators(2011)56 cited
- → Discovery of (2R)-2-(3-{3-[(4-Methoxyphenyl)carbonyl]-2-methyl-6-(trifluoromethoxy)-1H-indol-1-yl}phenoxy)butanoic Acid (MK-0533): A Novel Selective Peroxisome Proliferator-Activated Receptor γ Modulator for the Treatment of Type 2 Diabetes Mellitus with a Reduced Potential to Increase Plasma and Extracellular Fluid Volume(2009)52 cited
- → Discovery of novel, potent, selective, and orally active human glucagon receptor antagonists containing a pyrazole core(2010)47 cited
- → Effects of acetylpromazine, xylazine, and vertical load on digital arterial blood flow in horses(1994)43 cited
- → In vitro effects and in vivo efficacy of a novel cyclooxygenase-2 inhibitor in cats with lipopolysaccharide-induced pyrexia(2005)39 cited
- → EFFECT OF INTRAVENOUS INFUSION OF OMEGA-3 AND OMEGA-6 LIPID EMULSIONS ON EQUINE MONOCYTE FATTY ACID COMPOSITION AND INFLAMMATORY MEDIATOR PRODUCTION IN VITRO(2000)39 cited